The human vaccines project: into the immunome

Vaccine Insights 2022; 1(3), 5–8

DOI: 10.18609/vac.2022.002

Published: 27 May 2022
Wayne Koff

The Human Genome Project revolutionized biomedical research. Could mapping the immune system be the next frontier for human health? We caught up with the founder and CEO of the Human Vaccines Project, Wayne Koff, to find out how the initiative aims to decode the immune system and speed up vaccine development.

Charlotte Barker, Editor, Vaccine Insights speaks to Wayne Koff, Human Vaccines Project & Harvard TH Chan School of Public Health

Wayne Koff, PhD, is the founding president and CEO of the Human Vaccines Project and adjunct professor of epidemiology at the Harvard T.H. Chan School of Public Health. Prior to joining the Human Vaccines Project, Koff was chief scientific officer and senior vice president of research and development at the International AIDS Vaccine Initiative (IAVI) in New York City for 17 years. Earlier in his career, Koff held leadership roles including vice president of vaccine research and development at United Biomedical Inc. (UBI) and chief of the Vaccine Research and Development Branch, Division of AIDS, at the National Institute of Allergy and Infectious Diseases. An internationally recognized viral immunologist in the field of AIDS vaccine research and development, he has been twice honored by the US Department of Health and Human Services with the Special Act of Service Award for developing innovative strategies for accelerating global efforts in AIDS vaccine development.